Kyle Byron Womack MD M.S., FANA
Neuroimaging, Neurodegenerative, Dementia & Geriatrics
Professor of Neurology
Join to View Full Profile
1 Barnes Jewish Hospital Plz# DivSaint Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-286-1985
Dr. Womack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Dementia, Alzheimer's disease, Neurodegenerative disease, Neuroimaging, Frontotemporal Dementia & Primary Progressive Aphasias
Education & Training
University of Florida College of MedicineFellowship, Behavioral and Cognitive Neurology, 2000 - 2002
University of Texas Southwestern Graduate School of Biomedical SciencesMS, Biomedical Sciences, Neuroscience Track, 1997 - 2000
University of Texas Southwestern Medical CenterResidency, Neurology, 1988 - 1991- Texas Health Resources (Dallas)Internship, Internal Medicine, 1987 - 1988
University of Texas Southwestern Medical SchoolClass of 1987- Southern Methodist UniversityBA, Chemistry, Magna Cum Laude, 1979 - 1983
Certifications & Licensure
MO State Medical License 2020 - 2026
TX State Medical License 1988 - 2026
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesBehavioral Neurology & Neuropsychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Effects of ONO-2506PO in Patients With Alzheimer's Disease Start of enrollment: 2004 Jun 01
- Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's Start of enrollment: 2005 Feb 01
- A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration Start of enrollment: 2004 May 01
- Join now to see all
Publications & Presentations
PubMed
- Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.Dustin B Hammers, Jane Musema, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone
The Journal of Prevention of Alzheimer's Disease. 2025-04-01 - Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.Julien Lagarde, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang
Annals of Neurology. 2025-03-17 - Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach.Deepti Putcha, Yuta Katsumi, Alexandra Touroutoglou, Ani Eloyan, Alexander Taurone
Alzheimer's Research & Therapy. 2025-02-06
Press Mentions
UT Southwestern Researchers Find Increased Risk of Mild Cognitive Impairment Following Traumatic Brain InjuryMarch 15th, 2016
NFL Players May Be at Higher Risk for Depression as They AgeJanuary 16th, 2013
Grant Support
- North Texas Traumatic Brain Injury Research Center Model SystemsNIDRR2012–2017
- Novel Treatment of Emotional Dysfunction in PTSDCDMRP, DOD2011–2014
- Interhemispheric Information Transfer: A New DiagnosticDOD2010–2014
- Radiological Biomarkers For Frontotemporal Lobar DegenerationNational Institute On Aging2007–2011
Professional Memberships
- Member
- American Neurological AssociationMember
- International Neuropsychological SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
